Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11788108 CMP-dependent sialidase activity

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 23, 2021
Date of Patent
October 17, 2023
Patent Application Number
17355962
Patent Citations
‌
US Patent 8431355 Process for screening glycoform-specific antibodies
‌
US Patent 8993297 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity
‌
US Patent 9481902 Quantitative control of sialylation and specific mono-sialylation
‌
US Patent 9809835 Quantitative control of sialylation
‌
US Patent 10034921 Proteins with modified glycosylation and methods of production thereof
‌
US Patent 10526390 Pharmaceutical preparation comprising recombinant HcG
‌
US Patent 10660938 Recombinant FSH composition for treatment of infertility
‌
US Patent 10624953 Human-derived recombinant FSH for controlled ovarian stimulation
‌
US Patent 10995128 Pharmaceutical preparation
‌
US Patent 7510850 Isolation of the mitotic spindle matrix and its methods of use
•••
Patent Inventor Names
Marco Thomann
Michael Greif
Harald Sobek
Sebastian Malik
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11788108
Patent Primary Examiner
‌
Hope A Robinson

Find more entities like US Patent 11788108 CMP-dependent sialidase activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.